Clinicoepidemiological profile and practices to manage dizziness in primary care setting: results from an Indian registry

Authors

  • Divya Prabhat Department of ENT, Bhatia General, Hospital and B.J. Wadia Hospital, Mumbai, Maharashtra, India
  • Ganga Kiran Dr. Kiran's Diabetes clinic and Research Institute, Hyderabad, India

DOI:

https://doi.org/10.18203/issn.2454-5929.ijohns20210164

Keywords:

Betahistine, Clinicoepidemiological, Neurologic, Otologic, Prochlorperazine

Abstract

Background: Dizziness is a common symptom encountered in primary care settings by general physicians and specialists. This study evaluated the clinicoepidemiological profile and management practices in patients with dizziness in an Indian primary care setting.

Methods: This prospective, multicentric, observational study was conducted between November 2018 and June 2019. Patients aged≥18 years presenting with clinical features of dizziness were eligible. The study data included demographics and socioeconomic details, complete medical history, medication and concomitant medication use, and the cause and pattern of dizziness. Patients had a baseline visit and two follow-up visits at weeks 1 and 4.   

Results: Overall, 1000 patients with a mean age of 45.1 years were included (women: 51.5%; men: 48.5%). Of these, 762 reported dizziness as a primary complaint; whereas, 238 reported it as a complaint associated with nausea, vomiting and light-headedness on visit 1, which reduced on subsequent visits. Around 34% of the patients were unemployed and 59% belonged to the upper-middle class. The most common co-morbidities were hypertension and diabetes mellitus (n=132, each). More than 50% of the patients presented with vestibular cause (n=577), followed by neurologic (n=179), metabolic (n=84) and psychiatric (n=61) etiologies. Betahistine (n=581) and prochlorperazine (n=312) were the commonly prescribed medicines for primary and associated complaints. The most commonly used concomitant medications were telmisartan (n=53), glimepiride plus metformin (n=40), metformin (n=32) and ondansetron (n=29).  

Conclusions: Dizziness has a multifactorial origin necessitating a multifactorial treatment approach. Betahistine and prochlorperazine were the most commonly prescribed drugs in the primary care setting (CTRI/2018/11/016408).  

References

Bittar RS, Oiticica J, Bottino MA, Ganança FF, Dimitrov R. Population epidemiological study on the prevalence of dizziness in the city of São Paulo. Braz J Otorhinolaryngol. 2013;79:688-98.

Post RE, Dickerson LM. Dizziness: A diagnostic approach. Am Fam Physician. 2010;82:361-8.

Jung I, Kim JS. Approach to dizziness in the emergency department. ClinExpEmerg Med. 2015;2:75-88.

Neuhauser HK, Von Brevern M, Radtke A, Lezius F, Feldmann M, Ziese T, et al. Epidemiology of vestibular vertigo: a neurotologic survey of the general population. Neurology. 2005;65(6):898-904.

Skøien AK, Wilhemsen K, Gjesdal S. Occupational disability caused by dizziness and vertigo: a register-based prospective study. Br J Gen Pract. 2008;58:619-23.

Edlow JA, Gurley KL, Newman-Toker DE. A New Diagnostic Approach to the Adult Patient with Acute Dizziness. J Emerg Med. 2018;54:469-83.

Kerber KA, Newman-Toker DE. Misdiagnosing dizzy patients: Common pitfalls in clinical practice. Neurol Clin. 2015;33:565-75.

Muncie HL, Sirmans SM, James E. Dizziness: Approach to Evaluation and Management. Am Fam Physic. 2017;95:154-62.

Kerber KA. Vertigo and dizziness in the emergency department. Emerg Med Clin. 2009;27:39-50.

Mansour OI. Practical approach to the management of dizzy patients. J Otolaryngol 2013;29:49.

Jayarajan V, Rajenderkumar D. A survey of dizziness management in General Practice. J Laryngol Otol. 2003;117:599-604.

Yardley L, Owen N, Nazareth I, Luxon L. Prevalence and presentation of dizziness in a general practice community sample of working age people. Br J Gen Pract. 1998;48:1131-5.

Committee on Hearing and Equilibrium. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease. Otolaryngol Head Neck Surg. 1995;113:181-5.

Bhattacharyya N, Gubbels SP, Schwartz SR, Edlow JA, El-Kashlan H, Fife T, et al. Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (Update). Otolaryngol Head Neck Surg 2017;156:S1-S47.

Sura DS, Newell S. Vertigo-Diagnosis and management in primary care. Brit J Medic Practit. 2010;3:a351.

Havia M, Kentala E. Progression of Symptoms of Dizziness in Ménière's Disease. Arch Otolaryngol Head Neck Surg 2004;130:431-5.

Kurre A, Straumann D, van Gool CJ, Gloor-Juzi T, Bastiaenen CH. Gender differences in patients with dizziness and unsteadiness regarding self-perceived disability, anxiety, depression, and its associations. BMC Ear Nose Throat Disord. 2012;12:2.

Niemensivu R, Pyykko I, Wiener-Vacher SR, Kentala E. Vertigo and balance problems in children-an epidemiologic study in Finland. Int J Pediatr Otorhinolaryngol. 2006;70:259-65.

Humphriss RL, Hall AJ. Dizziness in 10-year-old children: an epidemiological study. Int J Pediatr Otorhinolaryngol. 2011;75:395-400.

Langhagen T, Albers L, Heinen F, Straube A, Filippopulos F, Landgraf MN, et al. Period Prevalence of Dizziness and Vertigo in Adolescents. PLoS One. 2015;10:e0136512.

Stevens KN, Lang IA, Guralnik JM, Melzer D. Epidemiology of balance and dizziness in a national population: findings from the English Longitudinal Study of Ageing. Validation of dizziness as a possible geriatric syndrome. Age Ageing 2008;37:300-5.

Kao AC, Nanda A, Williams CS, Tinetti ME.Validation of dizziness as a possible geriatric syndrome. J Am Geriatr Soc. 2001;49:72-5.

Lasisi AO, Gureje O. Prevalence and correlates of dizziness in the Ibadan Study of Ageing. Ear Nose Throat J. 2014;93:E37-44.

Bösner S, Schwarm S, Grevenrath P, Schmidt L, Hörner K, Beidatsch D, et al. Prevalence, aetiologies and prognosis of the symptom dizziness in primary care - a systematic review. BMC Fam Pract. 2018;19:33.

Martins TF, Mancini PC, Souza LD, Santos JN. Prevalence of dizziness in the population of Minas Gerais, Brazil, and its association with demographic and socioeconomic characteristics and health status. Braz J Otorhinolaryngol. 2017;83:29-37.

Maarsingh OR, Dros J, Schellevis FG, van Weert HC, Bindels PJ, Horst HE. Dizziness reported by elderly patients in family practice: prevalence, incidence, and clinical characteristics. BMC Fam Pract 2010;11:2.

Bazoni JA, Mendes WS, Meneses-Barriviera CL, Melo JJ, Costa VD, de Castro Teixeira D, et al. Physical activity in the prevention of benign paroxysmal positional vertigo: probable association 2014;18:387-90.

Sunami K, Tochino R, Tokuhara Y, Yamamoto H, Tomita S, Koshimo N, et al. Effects of cigarettes and alcohol consumption in benign paroxysmal positioning vertigo. Acta Otolaryngol 2006;126: 834-8.

Neuhauser HK, Radtke A, von Brevern M, Lezius F, Feldmann M, Lempert T. Burden of dizziness and vertigo in the community. Arch Intern Med. 2008;168: 2118-24.

Kameswaran M, Pujari S, Singh J, Basumatary LJ, Sarda K, Pore R. Clinic etiological pattern and pharmacotherapy practices in patients with new onset vertigo: findings from a prospective multicenter registry in India. Int J Otorhinolaryngol Head Neck Surg. 2017;32:404-13.

Talmud J, Edemekong P.Dix Hallpike Maneuver. StatPearls Publishing; 2020.

Huh YE, Kim JS. Bedside evaluation of dizzy patients. J Clin Neurol 2013;9:203-13.

Strupp M, Hupert D, Frenzel C, Wagner J, Hahn A, Jahn K et al. Long-term prophylactic treatment of attacks of vertigo in Menière's disease-comparison of a high with a low dosage of betahistine in an open trial. Acta Otolaryngol. 2008;128:520–4.

Parfenov VA, Golyk VA, Matsnev EI. Effectiveness of betahistine (48 mg/day) in patients with vestibular vertigo during routine practice: The VIRTUOSO study. PLoS One. 2017;12:e0174114.

Cavaliere M, Mottola G, Iemma M. Benign paroxysmal positional vertigo: a study of two manoeuvres with and without betahistine. Acta Otorhinolaryngol Ital. 2005;25:107-12.

Singh AK, Chaturvedi VN. Prochlorperazine versus cinnarizine in cases of vertigo. Indian J Otolaryngol Head Neck Surg. 1998;50:392-7.

Yardley L, Donovan-Hall M, Smith HE, Walsh BM, Mullee M, Bronstein AM. Effectiveness of primary care-based vestibular rehabilitation for chronic dizziness. Ann Intern Med. 2004;141:598-605.

Lacour M, van de Heyning PH, Novotny M, Tighilet B. Betahistine in the treatment of Ménière's disease. Neuropsychiatr Dis Treat. 2007;3:429-40.

Mira E, Guidetti G, Ghilardi L, Fattori B, Malannino N, Maiolino L et al. Betahistine dihydrochloride in the treatment of peripheral vestibular vertigo. Eur Arch Otorhinolaryngol. 2003;260:73-7.

Weiner CP, Mason M. Drugs for pregnant and lactating women. Elsevier. 3rd edition. 2019;651-750.

Recommended management of vestibular causes of dizziness Peter Rea MA, FRC Available at http://www.prescriber.co.uk/. Accessed on 22 April 2020.

Biswas A, Kirtane MV. Management of vertigo. Elsevier. 1st edition. 2013;45-51.

Huppert D, Strupp M,Rettinger N, Hecht J, Brandt T. Phobicpostural vertigo-a long-term follow-up (5 to 15 years) of 106patients. J Neurol 2005;252: 564-9.

Haldipur D, Krishnamurthy N, Bhavana A. The real-world safety and effectiveness of prochlorperazine in Indian patients with dizziness. J Assoc Physic Ind. 2020;68:61‐6.

Johansson M, Akerlund D, Larsen HC, Andersson G. Randomized controlled trial of vestibular rehabilitation combined with cognitive-behavioral therapy for dizziness in older people. Otolaryngol Head Neck Surg. 2001;125:151-6.

Holmberg J, Karlberg M, Harlacher U, Magnusson M. One-year follow-up of cognitive behavioral therapy for phobic postural vertigo. J Neurol. 2007;254:1189-92.

Wipperman J. Dizziness and Vertigo:clinics in office practice. Prim care. 2014;41:115-31.

Benecke H, Agus S, Kuessner D, Goodall G, Strupp M. The Burden and Impact of Vertigo: Findings from the REVERT Patient Registry. Front Neurol 2013;4:136.

Tinetti ME, Williams CS, Gill TM: Dizziness among older adults: a possible geriatric syndrome. Ann Intern Med. 2000;132:337-44.

Downloads

Published

2021-01-25

Issue

Section

Original Research Articles